Report Detail
Global (United States, European Union and China) Cognitive and Memory Enhancer Drugs Market Research Report 2019-2025
- RnM3653301 |
- 07 August, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.
The major factors that drive the growth of the global cognitive and memory enhancer drugs market include surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning propel the market growth. However, ethical issues related to the use of these drugs restrict the market growth.
In 2019, the market size of Cognitive and Memory Enhancer Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cognitive and Memory Enhancer Drugs.
This report studies the global market size of Cognitive and Memory Enhancer Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cognitive and Memory Enhancer Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Eisai Co
Allergan
Novartis
Shire
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript
Cephalon
Ceretropic
Market Segment by Product Type
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others
Market Segment by Application
Disease Treatment
Academic Performance
Athletic Performance
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cognitive and Memory Enhancer Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cognitive and Memory Enhancer Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cognitive and Memory Enhancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Aricept
- 1.3.3 Exelon
- 1.3.4 Namenda
- 1.3.5 Razadyne
- 1.3.6 Provigil
- 1.3.7 Ritalin
- 1.3.8 Adderall
- 1.3.9 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Cognitive and Memory Enhancer Drugs Market Share by Application (2019-2025)
- 1.4.2 Disease Treatment
- 1.4.3 Academic Performance
- 1.4.4 Athletic Performance
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cognitive and Memory Enhancer Drugs Market Size
- 2.1.1 Global Cognitive and Memory Enhancer Drugs Revenue 2014-2025
- 2.1.2 Global Cognitive and Memory Enhancer Drugs Sales 2014-2025
- 2.2 Cognitive and Memory Enhancer Drugs Growth Rate by Regions
- 2.2.1 Global Cognitive and Memory Enhancer Drugs Sales by Regions 2014-2019
- 2.2.2 Global Cognitive and Memory Enhancer Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers
- 3.1.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Cognitive and Memory Enhancer Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cognitive and Memory Enhancer Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Cognitive and Memory Enhancer Drugs Price by Manufacturers
- 3.4 Key Manufacturers Cognitive and Memory Enhancer Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cognitive and Memory Enhancer Drugs Market
- 3.6 Key Manufacturers Cognitive and Memory Enhancer Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Aricept Sales and Revenue (2014-2019)
- 4.1.2 Exelon Sales and Revenue (2014-2019)
- 4.1.3 Namenda Sales and Revenue (2014-2019)
- 4.1.4 Razadyne Sales and Revenue (2014-2019)
- 4.1.5 Provigil Sales and Revenue (2014-2019)
- 4.1.6 Ritalin Sales and Revenue (2014-2019)
- 4.1.7 Adderall Sales and Revenue (2014-2019)
- 4.1.8 Others Sales and Revenue (2014-2019)
- 4.2 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type
- 4.3 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type
- 4.4 Cognitive and Memory Enhancer Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cognitive and Memory Enhancer Drugs Sales by Application
6 United States
- 6.1 United States Cognitive and Memory Enhancer Drugs Breakdown Data by Company
- 6.2 United States Cognitive and Memory Enhancer Drugs Breakdown Data by Type
- 6.3 United States Cognitive and Memory Enhancer Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Cognitive and Memory Enhancer Drugs Breakdown Data by Company
- 7.2 European Union Cognitive and Memory Enhancer Drugs Breakdown Data by Type
- 7.3 European Union Cognitive and Memory Enhancer Drugs Breakdown Data by Application
8 China
- 8.1 China Cognitive and Memory Enhancer Drugs Breakdown Data by Company
- 8.2 China Cognitive and Memory Enhancer Drugs Breakdown Data by Type
- 8.3 China Cognitive and Memory Enhancer Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cognitive and Memory Enhancer Drugs Breakdown Data by Company
- 9.2 Rest of World Cognitive and Memory Enhancer Drugs Breakdown Data by Type
- 9.3 Rest of World Cognitive and Memory Enhancer Drugs Breakdown Data by Application
- 9.4 Rest of World Cognitive and Memory Enhancer Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Cognitive and Memory Enhancer Drugs Sales by Countries
- 9.4.2 Rest of World Cognitive and Memory Enhancer Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.1.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Eisai Co
- 10.2.1 Eisai Co Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.2.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.2.5 Eisai Co Recent Development
- 10.3 Allergan
- 10.3.1 Allergan Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.3.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.3.5 Allergan Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.4.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Shire
- 10.5.1 Shire Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.5.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.5.5 Shire Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.6.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 Takeda Pharmaceutical Company Limited
- 10.7.1 Takeda Pharmaceutical Company Limited Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.7.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.7.5 Takeda Pharmaceutical Company Limited Recent Development
- 10.8 AlternaScript
- 10.8.1 AlternaScript Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.8.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.8.5 AlternaScript Recent Development
- 10.9 Cephalon
- 10.9.1 Cephalon Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.9.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.9.5 Cephalon Recent Development
- 10.10 Ceretropic
- 10.10.1 Ceretropic Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cognitive and Memory Enhancer Drugs
- 10.10.4 Cognitive and Memory Enhancer Drugs Product Introduction
- 10.10.5 Ceretropic Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cognitive and Memory Enhancer Drugs Sales Channels
- 11.2.2 Cognitive and Memory Enhancer Drugs Distributors
- 11.3 Cognitive and Memory Enhancer Drugs Customers
12 Market Forecast
- 12.1 Global Cognitive and Memory Enhancer Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Type
- 12.3 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Application
- 12.4 Cognitive and Memory Enhancer Drugs Forecast by Regions
- 12.4.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cognitive and Memory Enhancer Drugs. Industry analysis & Market Report on Cognitive and Memory Enhancer Drugs is a syndicated market report, published as Global (United States, European Union and China) Cognitive and Memory Enhancer Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cognitive and Memory Enhancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
